0.17
-0.02(-10.53%)
Currency In USD
| Previous Close | 0.19 |
| Open | 0.16 |
| Day High | 0.19 |
| Day Low | 0.12 |
| 52-Week High | 3.86 |
| 52-Week Low | 0.17 |
| Volume | 616,100 |
| Average Volume | 223,615 |
| Market Cap | 722,541 |
| PE | -0.06 |
| EPS | -2.63 |
| Moving Average 50 Days | 1.25 |
| Moving Average 200 Days | 1.83 |
| Change | -0.02 |
If you invested $1000 in STRATA Skin Sciences, Inc. (SSKN) 10 years ago, it would be worth $3.43 as of February 21, 2026 at a share price of $0.17. Whereas If you bought $1000 worth of STRATA Skin Sciences, Inc. (SSKN) shares 5 years ago, it would be worth $8.02 as of February 21, 2026 at a share price of $0.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
STRATA Skin Sciences Confirms Nasdaq Delisting
GlobeNewswire Inc.
Feb 19, 2026 9:05 PM GMT
HORSHAM, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of der
Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
GlobeNewswire Inc.
Feb 18, 2026 1:15 PM GMT
Latest STRATA customer strengthens academic leadership in XTRAC excimer laser treatment for psoriasis, vitiligo, and atopic dermatitisHORSHAM, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN), a medical technology co
STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis
GlobeNewswire Inc.
Feb 17, 2026 1:15 PM GMT
Growing body of clinical data like February 2026 publication from Georgetown University supports optimized, targeted Excimer laser UVB strategies for inflammatory skin conditionsHORSHAM, Pa., Feb. 17, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences,